Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P39060 (endostatin)
 2,284 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Thanks to progress in zinc research, it is now possible to describe in more detail how zinc ions (Zn++) and nitrogen monoxide (NO), together with glutathione (GSH) and its oxidized form, GSSG, help to regulate immune responses to antigens. NO appears to be able to liberate Zn++ from metallothionein (MT), an intracellular storage molecule for metal ions such as zinc (Zn++) and copper (Cu++). Both Zn++ and Cu++ show a concentration-dependent inactivation of a protease essential for the proliferation of the AIDS virus HIV-1, while zinc can help prevent diabetes complications through its intracellular activation of the enzyme sorbitol dehydrogenase (SDH). A Zn++ deficiency can lead to a premature transition from efficient Th1-dependent cellular antiviral immune functions to Th2-dependent humoral immune functions. Deficiencies of Zn++, NO and/or GSH shift the Th1/Th2 balance towards Th2, as do deficiencies of any of the essential nutrients (ENs) - a group that includes methionine, cysteine, arginine, vitamins A, B, C and E, zinc and selenium (Se) - because these are necessary for the synthesis and maintenance of sufficient amounts of GSH, MT and NO. Via the Th1/Th2 balance, Zn++, NO, MT and GSH collectively determine the progress and outcome of many diseases. Disregulation of the Th1/Th2 balance is responsible for autoimmune disorders such as diabetes mellitus. Under Th2, levels of interleukin-4 (II-4), II-6, II-10, leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) are raised, while levels of II-2, Zn++, NO and other substances are lowered. This makes things easier for viruses like HIV-1 which multiply in Th2 cells but rarely, if ever, in Th1 cells. AIDS viruses (HIVs) enter immune cells with the aid of the CD4 cell surface receptor in combination with a number of co-receptors which include CCR3, CCR5 and CXCR4. Remarkably, the cell surface receptor for LTB4 (BLTR) also seems to act as a co-receptor for CD4, which helps HIVs to infect immune cells. The Th2 cytokine II-4 increases the number of CXCR4 and BLTR co-receptors, as a result of which, under Th2, the HIV strains that infect immune cells are precisely those that are best able to accelerate the AIDS disease process. The II-4 released under Th2 therefore not only promotes the production of more HIVs and the rate at which they infect immune cells, it also stimulates selection for the more virulent strains. Zn++ inhibit LTB4 production and numbers of LTB4 receptors (BLTRs) in a concentration-dependent way. Zn++ help cells to keep their LTB4 'doors' shut against the more virulent strains of HIV. Moreover, a sufficiency of Zn++ and NO prevents a shift of the Th1/Th2 balance towards Th2 and thereby slows the proliferation of HIV, which it also does by inactivating the HIV protease. Research makes it look likely that deficiencies of ENs such as zinc promote the proliferation of Th2 cells at the expense of Th1 cells. Zinc deficiency also promotes cancer. Under the influence of Th1 cells, zinc inhibits the growth of tumours by activating the endogenous tumour-suppressor endostatin, which inhibits angiogenesis. The modern Western diet, with its excess of refined products such as sugar, alcohol and fats, often contains, per calorie, a deficiency of ENs such as zinc, selenium and vitamins A, B, C and E, which results in disturbed immune functions, a shifted Th1/Th2 balance, chronic (viral) infections, obesity, atherosclerosis, autoimmunity, allergies and cancer. In view of this, an optimization of dietary composition would seem to give the best chance of beating (viral) epidemics and common (chronic) diseases at a realistic price.
 ...
PMID:Modern diets and diseases: NO-zinc balance. Under Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and cancer. 1049 17

This paper presents the first subtractively normalized interfacial Fourier transform infrared spectroscopic (SNIFTIRS) study of the corrosion system Ni/XCN(-) (X=O, S, Se), pH 11, [XCN(-)]=0.05 molL(-1), supporting electrolyte 0.1 molL(-1) KNO(3), for a nickel electrode as a function of applied potential. Cyclic voltammograms, in situ infrared spectra, and current-potential data (recorded while the infrared spectral acquisition was in progress) were recorded for a nickel electrode in a three-electrode thin-layer cell containing the pseudohalides OCN(-), SCN(-), or SeCN(-) ions at pH 11 in a supporting electrolyte of KNO(3). In general, the data showed that all of the pseudohalide ions studied caused corrosion of the nickel electrode by forming the respective nickel-pseudohalide complex ion species as the potential was stepped anodically. Two of the ions, SCN(-) and SeCN(-), caused surface modifications to the electrode which influenced the electrochemical reactions with respect to CO(2) formation. The Ni/SeCN(-) system, for instance, exhibited signs of instability during the spectroelectrochemical experiment, red-brown coatings observed on the electrode caused by the decomposition of the selenocyanate ion to colloidally dispersed elemental selenium. The selenium coated the electrode, hence modifying the surface and consequently the electrochemistry, by causing the "early" appearance of CO(2)-associated IR peaks in SNIFTIRS spectra recorded from the electrode system at potentials lower than those for the Ni/OCN(-) system. In contrast, CO(2) formation at the electrode surface was not observed in the Ni/SCN(-) system, which was likely to have been caused by nickel sulfide poisoning of the electrode surface. In the Ni/SCN(-) and Ni/SeCN(-) systems, IR spectra also indicated the buildup of Ni(SCN)(2) and Ni(SeCN)(2) salts in the thin layer by the appearance of a peak at ca. 2165 cm(-1) at anodic values of the applied potential.
 ...
PMID:In situ infrared spectroelectrochemical studies of the corrosion of a nickel electrode as a function of applied potential in cyanate, thiocyanate, and selenocyanate solutions. 1465 98

To overcome difficulties that hampered widespread application of a specific delivery system in cancer gene therapy and to inhibit the growth of solid liver cancer, we utilized a strain of Bifidobacterium longum as a delivery system to transport an endostatin gene that can inhibit growth of tumor. The B. longum strain with the endostatin gene (B. longum-En) was taken orally by tumor-bearing nude mice through drencher preparation. The results showed that B. longum-En could strongly inhibit the growth of solid liver tumor in nude mice and prolong the survival time of tumor-bearing nude mice. Furthermore, tumor growth was inhibited more efficiently when the B. longum-En treatment included selenium. Enriching the B. longum-En treatment with selenium improves the activity of NK and T cells and stimulates the activity of IL-2 and TNF-alpha in BALB/c mice. These results suggest that B. longum may be a highly specific and efficient vector for transporting anticancer genes in cancer gene therapy.
 ...
PMID:Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer. 1556 82

In the presence of selenium(IV) and molybdenum(VI) a new polarographic peak appears which corresponds to a hydrogen catalytic wave. By differential pulse polarography a single, sharp peak at about -1.1 V is obtained, allowing trace determination of selenium(IV) and molybdenum(VI) in the range 1x10(-6)-5.0x10(-9) M with a linear calibration and a detection limit of 1.5x10(-9) M. The optimum conditions are found to be 0.1 M KNO(3) and a pH of about 3.2 (Britton-Robinson buffer). There is no serious interference from some ions when present at 1.0-40 times that of molybdenum. At higher amounts of interfering ions the interference is eliminated by the addition of EDTA.
 ...
PMID:Differential pulse polarographic determination of trace selenium(IV) and molybdenum(VI) using the catalytic hydrogen wave. 1896 51

Bifidobacterium longum (B. longum) as a delivery system for endostatin was shown to have definite antitumor effects. Moreover, it was found that the enrichment of selenium was able to enhance the immunity of mice. In order to further evaluate the safety and efficacy of B. longum carrying pBV22210-endostatin (B. longum-En) enriched with selenium (Se-B. longum-En), we determined the biochemical characteristics of Se-B. longum-En. We then investigated its effect on macrophage activity, as well as its inhibitory effect on the multiplication of pathogenic bacteria in vitro and the antitumor effects on murine hepatic (H22) tumor-bearing mice. The results showed that Se-B. longum-En exhibited similar biochemical characteristics to that of wild-type B. longum, i.e., Se-B. longum-En strongly enhanced macrophage phagocytosis in rats and inhibited the growth of pathogenic bacteria. In addition, Se-B. longum-En showed a definite inhibitory effect of tumor growth when H22 tumor-bearing mice were fed through oral or tail vein delivery. These results suggested that Se-B. longum is able to retain the advantages of wild-type B. longum and be used as a novel gene delivery system for liver cancer gene therapy.
 ...
PMID:Selenium-Bifidobacterium longum as a delivery system of endostatin for inhibition of pathogenic bacteria and selective regression of solid tumor. 2313 5